Delivery Order SPE2DB22D1017-SPE2DB25FG0CQ
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication, with a ceiling value of $11,981.59 and a completion date of December 19, 2023. The contract is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,521.63 fixed-price contract is for the delivery of MICARDIS HCT 40-12.5 mg tablets through November 30, 2023. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.72, is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract is a firm-fixed price delivery order, with a completion date of November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $2,380.38 and covers the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a medication used to treat high blood pressure. The contract has an ultimate completion date of July 15, 2024. This contract is issued under a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,366.20, is for the provision of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product, to support military healthcare programs. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a prescription medication. The contract has a Ceiling Value of $2,594.40 and a period of performance through October 11, 2024. It is a Firm Fixed Price contract and does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is a delivery order with a ceiling value of $3,141.91, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication, with a period of performance through December 26, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product. The contract has a ceiling value of $1,148.01 and a completion date of August 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a $1,318.50 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication, with a period of performance through January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, with a completion date of February 2, 2024 and a potential value of $1,881.39. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp serves as the prime contractor,...